表紙
市場調查報告書

再生醫療的市場規模:技術,用途,各地區 - 佔有率,預測,機會分析(2020年∼2027年)

Regenerative Medicine Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968757
出版日期 內容資訊 英文 177 Pages
商品交期: 2-3個工作天內
價格
再生醫療的市場規模:技術,用途,各地區 - 佔有率,預測,機會分析(2020年∼2027年) Regenerative Medicine Market, By Technology, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月30日內容資訊: 英文 177 Pages
簡介

再生醫學可用於治療慢性和急性疾病,包括治療心血管疾病,皮膚傷口和某些類型的癌症。另外,當前的器官和組織移植僅限於供體供應,並且常常導致患者死亡或免疫系統嚴重並發症。再生醫學可以大大減輕這些問題。然而,高成本阻礙了再生醫學市場的增長。

本報告提供全球再生醫療市場的相關調查,提供市場趨勢和機會,成長及阻礙因素,技術·用途·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的·前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場展望

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各技術
    • 市場明細:各用途
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的發展
  • 法規方案
  • PEST分析
  • COVID-19影響分析

第4章 市場分析:各技術(2016-2027)

  • 簡介
  • 幹細胞
  • 生物材料
  • 人組織工程

第5章 市場分析:各用途(2016-2027)

  • 簡介
  • 移植骨替代物
  • 骨關節疾病
  • 同類骨
  • 自體骨
  • 其他

第6章 市場分析:各地區(2016-2027)

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第7章 競爭情形

  • 企業簡介
    • Anika Therapeutics, Inc.
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • DePuy Synthes, Inc.
    • Medtronic, Plc
    • Smith & Nephew plc
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.

第8章 章節

目錄

Title:
Regenerative Medicine (Bone and Joint) Market, By Technology (Stem Cell, Biomaterial, Tissue Engineering), By Application (Bone Graft, Substitutes Osteoarticular Diseases, Allogeneic Bones, Autogenic Bones, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases, dermal wounds, and in treatment of certain types of cancer. Furthermore, the current therapy of organ and tissue transplantation for treating organ and tissue failures can result in patient death due to limited or no donor supply and often result in severe complications in immune system. Regenerative medicine helps alleviate such issues to a major extent.

Restraints of the Global Regenerative Medicine (Bone and Joint) Market

Major factors hampering the growth of the regenerative medicine (bone and joint) market during the forecast period constitutes of high costs.

Key features of the study:

  • This report provides in-depth analysis of the global regenerative medicine (bone and joint) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global regenerative medicine (bone and joint) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Plc, Smith & Nephew plc, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global regenerative medicine (bone and joint) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Regenerative Medicine (Bone and Joint) Market, By Technology:
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • Global Regenerative Medicine (Bone and Joint) Market, By Application:
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • Global Regenerative Medicine (Bone and Joint) Market, By Geography:
    • North America
  • By Technology
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Technology
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Technology
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Technology
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Technology
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Technology
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Anika Therapeutics, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • DePuy Synthes, Inc.
    • Medtronic, Plc
    • Smith & Nephew plc
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • COVID-19 Impact Analysis

4. Global Regenerative Medicine (Bone and Joint) Market, By Technology, 2016 - 2027 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
  • Stem Cell
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Segment Trends
  • Biomaterial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Segment Trends
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Segment Trends

5. Global Regenerative Medicine (Bone and Joint) Market, By Application, 2016 - 2027 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
  • Bone Graft Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Osteoarticular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Allogeneic Bones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Autogenic Bones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Regenerative Medicine (Bone and Joint) Market, By Regions, 2016 - 2027 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017-2027
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Company Profiles
    • Anika Therapeutics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Arthrex, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Baxter International, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CONMED Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • DePuy Synthes, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic, Plc
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Smith & Nephew plc
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Stryker Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Zimmer Holdings, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aziyo Biologics
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ortho Regenerative Technologies Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact

*Browse 34 market data tables and 23 figures on "Regenerative Medicine (Bone and Joint) Market - Global forecast to 2027".